Scilex Holding Company

SCLX

$32M

Micro Cap

NASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaPALO ALTO

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Aug 12, 2026

Market Overview

Stock performance and key metrics

SCLX News

Catalyst Timeline

1 upcoming, 0 past

No catalysts found.

1 more catalyst beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

Drug Pipeline

SP-102

Phase 3

Lumbosacral Radicular Pain

SP-103

Phase 2

Moderate to Severe Acute Lower Back Pain

Drug Name	Phase	Indication	Designations	Patent
SP-102	Phase 3	Lumbosacral Radicular Pain	-	-
SP-103	Phase 2	Moderate to Severe Acute Lower Back Pain	-	-

Catalyst Verdict

Market-Implied Move

Regulatory Approvals

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Scilex Holding Company

Market Overview

SCLX News

Catalyst Timeline

Pipeline & FDA Submissions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals